| I-084 Oleg Demin Jr Optimizing first-in-human dose for HPN536, a T-Cell Engager Targeting Mesothelin: comparison of MABEL PK-driven approach and mechanistic translational PK/RO/PA modeling Wednesday 10:20-11:50 |
| I-084 Oleg Demin Jr Optimizing first-in-human dose for HPN536, a T-Cell Engager Targeting Mesothelin: comparison of MABEL PK-driven approach and mechanistic translational PK/RO/PA modeling Wednesday 10:20-11:50 |